APN

Apeiron Capital Investment Corp. APN

Trading inactive

APN
Apeiron Capital Investment Corp. BBOT
BridgeBio Oncology Therapeutics Inc. CONX
Direxion Daily COIN Bull 2X ETF THAC
Thrive Acquisition Corporation CFIV
CF Acquisition Corp. IV LFAC
LF Capital Acquisition Corp. II ASAX
Astrea Acquisition Corp. FIAC
Focus Impact Acquisition Corp. ZVSA
ZyVersa Therapeutics, Inc. GWII
Good Works II Acquisition Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode APN BBOT CONX THAC CFIV LFAC ASAX FIAC ZVSA GWII
6M 3.18 % 16.02 % 13.85 % 2.32 % 0.86 % 2.75 % 2.13 % -20.00 % -80.00 % 1.00 %
YTD 1.17 % 14.01 % 13.85 % 0.53 % 0.00 % 5.35 % 0.00 % -18.46 % -87.16 % -0.88 %
1Y 4.43 % 18.77 % 13.85 % 4.07 % 4.86 % 7.01 % 3.38 % -18.68 % -87.72 % 2.59 %
3Y 4.75 % 22.96 % 13.85 % 4.81 % 1.44 % 3.04 % 4.13 % -10.30 % -100.00 % 3.16 %
5Y 4.75 % 22.96 % 13.85 % 4.81 % 1.44 % 13.27 % 4.13 % -10.30 % -100.00 % 3.16 %
10Y 4.75 % 22.96 % 13.85 % 4.81 % 1.44 % 12.56 % 4.13 % -10.30 % -100.00 % 3.16 %
From the beginning 40.51 % 22.96 % 13.85 % 4.81 % 1.44 % 12.56 % 4.13 % -10.30 % -100.00 % 3.16 %

Dividend